Yes, Advair Diskus 500/50 is the highest available strength of this inhaler and is classified as a high-dose inhaled corticosteroid combination. It contains 500 micrograms of fluticasone propionate (a steroid that reduces airway inflammation) paired with 50 micrograms of salmeterol (a long-acting bronchodilator that keeps airways open). The FDA labels it as the maximum recommended dosage for asthma, and it sits at the top of the dosing ladder for this medication.
How the Three Strengths Compare
Advair Diskus comes in three strengths, all taken as one inhalation twice daily. The difference between them is the amount of steroid in each puff:
- 100/50: 100 mcg fluticasone + 50 mcg salmeterol (low dose)
- 250/50: 250 mcg fluticasone + 50 mcg salmeterol (medium dose)
- 500/50: 500 mcg fluticasone + 50 mcg salmeterol (high dose)
The salmeterol component stays the same across all three. What changes is the steroid load. At 1,000 mcg of fluticasone per day (500 mcg twice), the 500/50 strength delivers five times more steroid than the lowest strength. The American Lung Association’s comparative dosing chart lists two puffs daily of the 500/50 strength as a high daily dose for adults and adolescents over 12.
When the 500/50 Strength Is Prescribed
Doctors typically reserve the 500/50 strength for people whose asthma isn’t well controlled on lower doses. The standard approach in asthma management is to start at a lower or medium strength and step up only if symptoms persist after about two weeks. If the 100/50 or 250/50 isn’t keeping your symptoms in check, your doctor may move you to 500/50 as the next step. It’s not where most people start.
This stepwise approach follows global asthma guidelines, which recommend gradually increasing medication strength rather than jumping straight to high-dose therapy. The goal is always to use the lowest effective dose that keeps your asthma controlled, then step back down when possible.
A Different Story for COPD
If you have COPD rather than asthma, the 500/50 strength occupies an unusual position. In the United States, the FDA has approved only the 250/50 strength for COPD. The reason: clinical trials did not demonstrate a clear benefit of 500/50 over 250/50 for COPD patients. Both doses reduced moderate and severe flare-ups by about 30% compared to using a bronchodilator alone.
Interestingly, the picture differs in Europe, where the 500/50 dose is the approved strength for COPD, based largely on a major three-year trial called TORCH. In that study, the 500/50 dose reduced moderate-to-severe flare-ups by 25% compared to placebo and 12% compared to salmeterol alone. So if you’re using Advair for COPD in the U.S. and your doctor has prescribed the 500/50 strength, it’s being used off-label, which isn’t unusual in clinical practice but is worth understanding.
Side Effects at Higher Steroid Doses
The steroid in Advair is inhaled, so most of it stays in your lungs and throat rather than circulating through your whole body. But at the 500/50 level, more of it does get absorbed systemically, and the risk of certain side effects increases compared to lower strengths.
The most common local side effects are oral thrush (a yeast infection in the mouth) and hoarseness. These happen because the steroid settles on the tissues of your mouth and throat. Rinsing your mouth with water after each use and spitting it out significantly reduces this risk.
The bigger concern with long-term high-dose inhaled steroids is their effect on your body’s natural cortisol production. Your adrenal glands make cortisol on their own, and when you inhale large amounts of synthetic steroid, those glands can dial back their output. A meta-analysis of clinical studies found that adrenal suppression occurred in roughly 30% to 78% of people using fluticasone at the 500 mcg dose level, depending on the study and how suppression was measured. Most people don’t feel symptoms from this, but it matters if you suddenly stop the medication or become seriously ill, because your body may not produce enough cortisol on its own to respond to stress.
Long-term use of high-dose inhaled steroids has also been linked to slightly reduced bone density, easy bruising, and a small increase in cataract risk. These effects tend to develop over years, not weeks, and they’re dose-dependent, which is exactly why guidelines emphasize using the lowest dose that controls your symptoms.
How It Compares to Other Inhalers
If you’re wondering whether 500/50 is “a lot” compared to other combination inhalers on the market, it helps to know that different steroids have different potencies, so the numbers aren’t directly interchangeable. Advair 500/50 twice daily is roughly equivalent in steroid potency to the highest tier of other combination inhalers like Breo Ellipta (which uses a once-daily formulation of 200/25 mcg at its higher strength) or Symbicort at its maximum dosing. All of these sit in the high-dose category when used at their top strengths.
One practical difference: Breo Ellipta is taken once daily, while Advair requires twice-daily dosing. The total steroid exposure over 24 hours is what determines whether you’re in the low, medium, or high range, not the number on a single puff.
What “High Dose” Means for You
Being on the 500/50 strength doesn’t mean your condition is dangerous or that you’re overmedicated. It means your airways need more anti-inflammatory support than a lower dose provides. Many people with moderate-to-severe persistent asthma use high-dose inhaled steroids for years and do well on them.
That said, if you’ve been on the 500/50 strength for a while and your asthma has been stable, it’s reasonable to ask your doctor whether stepping down to the 250/50 might still keep things controlled. Guidelines recommend reassessing every few months. Dropping to a lower strength, when possible, reduces your cumulative steroid exposure over time and lowers the risk of the side effects described above. Some people genuinely need the 500/50 long-term, but others may have been started on it during a rough patch and never stepped back down.